Xiaojun Xia
Haikou, 571199, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Cell-based cancer immunotherapy: milestones, mechanistic insights, and emerging therapeutic directions.
Journal: Acta pharmacologica Sinica
Published: January 22, 2026
A STING signaling relay from tumor cells to macrophages mediates the improved efficacy of combination chemotherapy in pancreatic cancer.
Journal: Journal of biomedical science
Published: August 19, 2025
STING synergizes with TOX suppressing HO-1 expression to trigger ferroptosis in tumor-infiltrating CD8+ T cell and immunotherapy resistance.
Journal: Nature communications
Published: May 27, 2025
RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity.
Journal: Journal for immunotherapy of cancer
Published: April 14, 2025
Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity.
Journal: The EMBO journal
Published: January 30, 2024
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 07, 2024
A near-infrared fluorescence-enhancing plasmonic biosensing microarray identifies soluble PD-L1 and ICAM-1 as predictive checkpoint biomarkers for cancer immunotherapy.
Journal: Biosensors & bioelectronics
Published: January 18, 2023
Advances in mRNA vaccines.
Journal: International review of cell and molecular biology
Published: September 05, 2022
T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
Journal: Journal for immunotherapy of cancer
Published: August 29, 2022
An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma.
Journal: Cancer cell
Published: July 22, 2022
Last Updated: 09/26/2026